Study Details

Back to Search Results

A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects with Limitations in Mobility

Terminated/Withdrawn
The study has stopped early and will not start again. Participants were not enrolled (for withdrawn studies), however if participants were enrolled, they are no longer being examined or treated.

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT03065959

Astellas Study ID

The unique identification code given by the study sponsor.

3318-CL-3001

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Mobility Limitation with Fatigue

Phase

These clinical trials are usually the first time an experimental treatment is studied in a small group of people.

Phase 1

Age

65 years - 89 years

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Jun 2017 - Oct 2018

Masking

Double (Participant, Investigator)

Enrollment number

42

A Phase 1b Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects with Limitations in Mobility

Study summary

Study documents

Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects with Limitations in Mobility? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Tufts Medical Center

Boston, United States, 02111-1524

University of Florida

Gainesville, United States, 32611

Wake Forest University School of Medicine

Winston-Salem, United States, 27157

Mayo Clinic

Rochester, United States, 55905

Washington University School of Medicine

St. Louis, United States, 63110-1010

Ohio University Heritage College

Athens, United States, 45701

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo